NanoRepro AG Logo

NanoRepro AG

ISIN: DE0006577109 | Ticker: NN6 | LEI: 3912008FCA63AGIMEV74

About NanoRepro AG

Company Description

NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention.

The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years.

NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.

Year founded

2006

Served area

Worldwide

Headquarters

Untergasse 8, 35037 Marburg – Germany

Filings & Publications

2021

Report Q1 H1 Q3 FY
Consolidated Report GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2022

Report Q1 H1 Q3 FY
Consolidated Report GER
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding

12,900,000

IPO

Oct. 10, 2008

Stock exchange(s)

Frankfurt Stock Exchange

Contact Investor Relations department

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.